AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical
treatments for atrial fibrillation and Left Atrial Appendage Management,
will release its financial results for the fourth quarter and full year
2014 on Monday, February 23, 2015.
Sign-up for 2015/2/2 - Artisan Partners Asset Management Inc. Reports Quarter and Year Ended December 31, 2014 Results, Quarterly Dividend of $0.60 Per Share and a Special Annual Dividend of $0.95 Per Share investment picks
By Jennifer Booton, MarketWatch
GoPro is expected to post strong holiday sales of entry-level Hero
NEW YORK (MarketWatch) -- GoPro Inc. is expected to report fourth-quarter earnings after the market closes on Thursday.
Levi & Korsinsky announces that a class action lawsuit has been
commenced in the USDC for the Eastern District of New York on behalf of
investors who purchased Jumei International Holding Limited (“Jumei” or
the “Company”) (NYSE:JMEI) securities between its May 16, 2014 Initial
Public Offering and November 20, 2014.
Sign-up for 2015/2/2 - UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action against Jumei International Holding Limited and Its Board of Directors and a Lead Plaintiff Deadline of February 10, 2015 investment picks
bluebird bio, Inc. (Nasdaq:BLUE) a clinical-stage company committed to
developing potentially transformative gene therapies for severe genetic
and rare diseases, today announced that the U.S. Food and Drug
Administration (FDA) has granted Breakthrough Therapy designation to
LentiGlobin ® BB305 Drug Product for the treatment of
transfusion-dependent patients with beta-thalassemia major.
Boys & Girls Clubs of America (BGCA) and University of Phoenix, a
subsidiary of Apollo Education Group, Inc. ( Nasdaq:
APOL ), have once again partnered to find and reward America’s most
By Sue Chang and MarketWatch, MarketWatch
Sysco Corp.'s Q2 earnings were in line
NEW YORK (MarketWatch) -- These are the stocks likely to make notable moves in the market on Monday:
Tickers to Watch
Exxon Mobil(XOM) is projected to report fourth-quarter earnings of $1.34 a share, according to a consensus survey by FactSet.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.